Integrated Care Boosts Smoking Cessation When Undergoing Lung Cancer Screening

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Jan. 17, 2025 -- Integrated care (IC) involving medication and intensive counseling provides the best opportunity for smoking cessation in the context of lung cancer screening (LCS), according to a study published online Jan. 13 in JAMA Internal Medicine.

Paul M. Cinciripini, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues evaluated the efficacy of three tobacco treatment strategies in the LCS setting. The analysis included 630 participants randomly assigned to quitline (QL; including 12-week nicotine replacement therapy [NRT]), QL plus 12-week NRT or pharmacotherapy (QL+), or IC (12-week NRT or prescription pharmacotherapy and counseling).

The researchers found that at three months, 25.2 percent in QL, 27.1 percent in QL+, and 37.1 percent in IC reported abstinence. IC performed better than both QL (odds ratio, 1.75) and QL+ (odds ratio, 1.58). IC maintained the highest rate of abstinence at six months, with 32.4 percent, followed by QL+ at 27.6 percent, and QL at 20.5 percent (IC versus QL: odds ratio, 1.86). IC showed a higher probability of positive absolute risk differences (ARDs) in abstinence at three months versus QL (ARD, 0.12) in the Bayesian analysis with 99 percent probability of positive ARD and versus QL+ (ARD, 0.10) with 98 percent probability of positive ARD. At six months, this advantage was maintained with ARDs of 0.12 versus QL (probability of positive ARD, 99 percent) and 0.05 versus QL+ (probability of positive ARD, 86 percent).

"The superior performance of the IC model underscores the value of integrated, comprehensive approaches to smoking cessation in the LCS setting, which could be an important consideration when referring patients for screening," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords